Navigation Links
MiMedx Announces Record First Quarter 2013 Results
Date:5/1/2013

KENNESAW, Ga., May 1, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NasdaqCM: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended March 31, 2013.

Highlights of First Quarter 2013 Results include:

  • Revenue exceeded forecast for fifth consecutive quarter
  • Revenue more than triples over first quarter of 2012
  • Fifth consecutive quarter of positive Adjusted EBITDA
  • Gross Margins improved by 10 percent over Q1 of prior year
  • Company reiterates 2013 guidance
  • First Quarter 2013 ResultsThe Company recorded record revenue for the quarter ended March 31, 2013, with revenue of $11.6 million, a three-fold increase over first quarter of 2012 revenue of $3.7 million. The Company's first quarter gross margins were 84% as compared to 74% in the first quarter of last year. Earnings before interest, taxes, depreciation, amortization and share based compensation (Adjusted EBITDA*) for the first quarter of 2013 were $1.1 million, a $805,000 or 256% improvement, as compared to the Adjusted EBITDA of $314,000 for the first quarter of 2012. The Net loss for the quarter was $1.6 million which included a one-time charge of $1.3 million for debt discount related to the conversion of our senior secured promissory notes.

    Management Commentary on First Quarter ResultsParker H. "Pete" Petit, Chairman and CEO, stated, "We are pleased that our revenue performance exceeded the $11.5 million upper range of our guidance. We increased revenue three fold over the prior year first quarter and continued to produce strong gross profit margins, equaling our fourth quarter of 2012 record gross margins of 84%. We are pleased to report our fifth consecutive quarter of positive Adjusted EBITDA, however, we continue to balance the investments in our sales org
    '/>"/>

    SOURCE MiMedx Group, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related biology technology :

    1. MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
    2. MiMedx Group, Inc. Announces Release Date for 2013 First Quarter Results
    3. MiMedx Responds To Inquiries Regarding Trading Activity; Reiterates First Quarter And Full Year Goals
    4. MiMedx to Present at the Canaccord Genuity Musculoskeletal Conference
    5. MiMedx Is Issued Four Additional U.S. Patents For Placental Tissue Grafts
    6. MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
    7. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
    8. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
    9. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
    10. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
    11. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/20/2014)... Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced four new ... and provides a good start to Q4.  The orders are for ... and one in the Middle East . ... Peter Bruijns , President & CEO. "Total bidding activity and ... have been for any complete year since the company has tracked ...
    (Date:10/20/2014)... October 20, 2014 OncLive® ... Kimmel Cancer Center at Thomas Jefferson University has ... Through the Strategic Alliance Partnership program, the Sidney ... collaborate to raise awareness of the Center’s cutting-edge ... other projects. Clinicians and other health care professionals ...
    (Date:10/19/2014)... OCTOBER 20-22, 2014: The ... ABIM will take place at the Congress ... 2014 is now available at http://www.abim.ch ... and organizations from all over the globe ... the latest products and developments on the ...
    (Date:10/19/2014)... The Asia-Pacific Speech Analytics market report ... with analysis and forecast of revenue. This market is ... $208 million by 2019, at a Compound Annual Growth ... Browse through the TOC of the Asia-Pacific Speech Analytics ... analysis provided. It also provides a glimpse of the ...
    Breaking Biology Technology:Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4
    ... , PRINCETON, N.J., July 15 ... a license agreement with Merck KGaA, Darmstadt, Germany, providing the ... Technology platform for the research, development and commercialization of their ... , "We are extremely pleased ...
    ... July 14 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ: VSGN ; ... and six months ended May 31, 2009. All dollar amounts ... At May 31, 2009, our cash and cash equivalents totaled ... Our net cash used in operating activities for the three ...
    ... , , , LAKE ... technology company focused on improving blood collection, separation, safety and ... agreement with Verax Biomedical Incorporated to market, sell and distribute ... used to detect bacterial contaminants in donated blood platelets. ...
    Cached Biology Technology:BioWa Announces License of POTELLIGENT(R) Technology to Merck KGaA 2Vasogen Announces Second Quarter 2009 Results 2Vasogen Announces Second Quarter 2009 Results 3Vasogen Announces Second Quarter 2009 Results 4Vasogen Announces Second Quarter 2009 Results 5Vasogen Announces Second Quarter 2009 Results 6Vasogen Announces Second Quarter 2009 Results 7Vasogen Announces Second Quarter 2009 Results 8Vasogen Announces Second Quarter 2009 Results 9Vasogen Announces Second Quarter 2009 Results 10Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 2Improving Transfusion Safety: Fenwal, Verax Biomedical Sign Agreement for Rapid, Point-of-Care Bacteria Test 3
    (Date:10/14/2014)... – Scientists have sequenced the house fly genome for ... might expect from an insect that thrives in pathogen-rich ... Oct. 14 in the journal Genome Biology , ... and of how flies quickly adapt to resist insecticides, ... house flies (Musca domestica) carry and transmit more than ...
    (Date:10/14/2014)... – October 14, 2014 – Scientists from The Scripps ... the National Institutes of Health (NIH) to lead an ... hemorrhagic fever disease in Africa. The study aims to ... some patients die, while others survive the inflection. ... the basic mechanism of how Lassa fever virus causes ...
    (Date:10/14/2014)... October 14, 2014 – Over the past decades, we ... institutions to meet the needs of infants for social ... these infants to thrive. , Infancy and ... of the cortex. A generation of research suggests that ... cortical development and cognitive function. In contrast, deprivation and ...
    Breaking Biology News(10 mins):House fly genome reveals expanded immune system 2Scripps Research Institute team receives $6.6 million to investigate deadly Lassa virus 2Institutional rearing may increase risk attention-deficit disorder 2
    ... a team led by researchers from Caltech has for ... of chemoreceptorsthe receptors that sense and respond to chemical ... specific architecture is the same throughout a wide variety ... stable, universal structure that has been conserved over evolutionary ...
    ... new university/industry network to pursue the development of biomaterials, ... increasing incidence of eye disease. The 20/20: NSERC ... as part of the Natural Sciences and Engineering Research ... Minister of State (Science and Technology) Gary Goodyear today ...
    ... cell researcher Treena Livingston Arinzeh will discuss current stem cell ... for bone fracture and osteoarthritis treatments, spinal cord repair, and ... The event will be held Sept. 29, 2009, at ... floor of the NJIT Campus Center. The ...
    Cached Biology News:Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 2Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 3Caltech scientists get detailed glimpse of chemoreceptor architecture in bacterial cells 4New research network at McMaster aims to build a better eye 2
    Request Info...
    Designed for use with any of the Agencourt kits in tube format....
    Collected from animals that are 16 to 18 months old. Sterile, Cell culture tested, ID clarifier: USA Origin...
    ... glass plates, bar clamp, and a built-in ... these units are:, safety interlock lids , ... upper and lower reservoirs have drains with ... of buffer solutions , leveling base with ...
    Biology Products: